GOSS Earnings

Quarterly EPS
$-0.14
Q3 2024
$-0.15
Q4 2024
$-0.16
Q1 2025
$-0.17
Q2 2025
$-0.21
Q3 2025
$-0.20
Q4 2025
$-0.20
Q1 2026
$0.05
Q2 2026
Latest Revenue9.2M
Latest Net Income16.9M
EPS & Revenue Trend
PeriodEPSRevenueNet IncomeRev YoYEPS YoY
Q2 2026$0.059.2M16.9M-19.6%+129.4%
Q1 2026-$0.2017.0M-46664000+71.5%-25.0%
Q4 2025-$0.2013.8M-47238000+47.1%-33.3%
Q3 2025-$0.2113.3M-48221000+40.2%-50.0%
Q2 2025-$0.1711.5M-38273000-88.0%-177.3%
Q1 2025-$0.169.9M-36638000+15.8%
Q4 2024-$0.159.4M-33029000+28.6%
Q3 2024-$0.149.5M-30803000+33.3%
Q2 2024$0.2295.8M49.2M
Q1 2024-$0.190-41928000
Q4 2023-$0.210-48148000
Q3 2023-$0.210-40008000
Gossamer Bio (GOSS) — Earnings